title: Limited Funds for Bladder Cancer Research and What Can We Do About It.
abstract: Bladder cancer is frequent, has a high mortality, is expensive and treatment options have not improved over a long time. One of the most important reasons for the relative lack of improvement in treatment of bladder cancer is the low funding for research on bladder cancer. A second reason is that incidence figures in some countries are too low because non-muscle invasive tumors are not registered. We suggest that the bladder cancer community advocates research on bladder cancer and informs policy makers on the underfunding situation. In addition, we need to convince the statisticians that registration should encompass all bladder tumors.
authors.affiliation: Erasmus MC Cancer Institute , Departments of Urology and Pathology, Rotterdam, The Netherlands.
authors.forename: Joost L
authors.initials: JL
authors.lastname: Boormans
authors.affiliation: Erasmus MC Cancer Institute , Departments of Urology and Pathology, Rotterdam, The Netherlands.
authors.forename: Ellen C
authors.initials: EC
authors.lastname: Zwarthoff